Homepage
Medication Guide
Indications for Enasidenib
Enasidenib is an isocitrate dehydrogenase-2 (IDH2) inhibitor indicated for the treatment of relapsed or refractory acute myeloid leukemia (AML) with specific gene mutation types.Indications for Enasid...
504
Friday, November 14th, 2025, 10:31
Procurement Channels for Enasidenib
Enasidenib is a targeted medication for the treatment of relapsed or refractory acute myeloid leukemia (AML). Its rational use is of crucial importance to patients. Due to the specific nature of this ...
505
Friday, November 14th, 2025, 10:27
Precautions for Administration of Teneligliptin Hydrobromide/Canagliflozin Combination Tablets (Canalia)
Teneligliptin Hydrobromide/Canagliflozin Combination Tablets (Canalia) is a fixed-dose combination preparation of a DPP-4 inhibitor and an SGLT2 inhibitor developed by Mitsubishi Tanabe Pharma (Japan)...
509
Friday, November 14th, 2025, 10:14
Indications for Teneligliptin Hydrobromide/Canagliflozin Combination Tablets (Canalia)
Teneligliptin Hydrobromide/Canagliflozin Combination Tablets (Canalia) is a dual-mechanism antidiabetic fixed-dose combination preparation developed by Mitsubishi Tanabe Pharma (Japan) and co-promoted...
505
Friday, November 14th, 2025, 10:11
How to Purchase Teneligliptin Hydrobromide/Canagliflozin Combination Tablets (Canalia)
Teneligliptin Hydrobromide/Canagliflozin Combination Tablets (Canalia) is a dual-target (DPP-4 and SGLT2) fixed-dose combination preparation developed by Mitsubishi Tanabe Pharma (Japan). It demonstra...
508
Friday, November 14th, 2025, 10:03
Indications for Vigabatrin (Sabril)
Vigabatrin (Sabril) is an antiepileptic drug commonly used to treat specific types of seizures, particularly in cases where other treatments have shown poor efficacy. Understanding its indications, do...
505
Friday, November 14th, 2025, 09:58
How to Use Repotrectinib (Augtyro)
Repotrectinib (Augtyro) is a novel kinase inhibitor that received its first approval in the United States in 2023. This medication is primarily indicated for the treatment of ROS1-positive non-small c...
506
Friday, November 14th, 2025, 09:52
Indications for Repotrectinib (Augtyro)
Repotrectinib (Augtyro) is an innovative kinase inhibitor that received its first approval from the U.S. Food and Drug Administration (FDA) in 2023. As a next-generation targeted therapy, repotrectini...
505
Friday, November 14th, 2025, 09:48
How to Purchase Repotrectinib (Augtyro)
Repotrectinib (Augtyro) is a next-generation kinase inhibitor and an important targeted medication for the treatment of ROS1-positive non-small cell lung cancer (NSCLC) and NTRK gene fusion-positive s...
502
Thursday, November 13th, 2025, 13:21
What Are the Side Effects of Rasagiline (Azilect)?
Rasagiline (Azilect) is a selective and irreversible monoamine oxidase type B (MAO-B) inhibitor, approved for the treatment of Parkinson's disease. While this medication effectively improves motor...
504
Thursday, November 13th, 2025, 13:16
50 / 200
1996 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved